Biocon Biologics

Biocon Biologics

Biotechnology, Hosur Rd Bengaluru, Bengaluru, Indiana, United States, 5001-10000 Employees

bioconbiologics.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: +17*********

Who is BIOCON BIOLOGICS

Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advan...

Read More

map
  • Hosur Rd Bengaluru, Bengaluru, Indiana, United States Headquarters: Hosur Rd Bengaluru, Bengaluru, Indiana, United States
  • 1978 Date Founded: 1978
  • 5001-10000 Employees: 5001-10000
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC NAICS Code: 621111 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from BIOCON BIOLOGICS

Biocon Biologics Org Chart and Mapping

Employees

Stephen Manzano

Senior Vice President, Chief Legal Officer - Advanced Markets

Doug Fernandes

Vice President Market Access & Pricing - Advanced Markets

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Biocon Biologics

Answer: Biocon Biologics's headquarters are located at Hosur Rd Bengaluru, Bengaluru, Indiana, United States

Answer: Biocon Biologics's phone number is +17*********

Answer: Biocon Biologics's official website is https://bioconbiologics.com

Answer: Biocon Biologics's revenue is $1 Million to $5 Million

Answer: Biocon Biologics's NAICS: 621111

Answer: Biocon Biologics has 5001-10000 employees

Answer: Biocon Biologics is in Biotechnology

Answer: Biocon Biologics contact info: Phone number: +17********* Website: https://bioconbiologics.com

Answer: Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients worldwide. Follow-us on Twitter: @BioconBiologics

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access